REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
27/07/2026
Voltar para busca
Dado oficial do USPTO
SMART-FC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SMART-FC
ST13
US500000079277724Classe
5, 42, 45
Pedido
79277724
Registro
6430408
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
27/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 45
Data de depósito
25/09/2019
Data de registro
27/07/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/07/2021
Última transação
27/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
JP
Examinador
LAMONT, JOHN CHRISTOPHER
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)
Representantes
Bassam N. Ibrahim Buchanan Ingersoll & Rooney PC
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for human usespecificallyantibodies and their fragments and derivativescells and genes that produce antibodiesfragments of antibodies and derivatives of antibodiesall for preventing or treating infectious and parasitic diseasescancerblood and blood-forming organs diseases and disorders involving the immune mechanismendocrinenutritional and metabolic diseasesmental and behavioral disordersdiseases of the nervous systemdiseases of the eye and adnexadiseases of the ear and mastoid processdiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin and subcutaneous tissuediseases of the musculoskeletal system and connective tissuediseases of the genitourinary systempregnancychildbirth and the puerperiumcongenital malformationsdeformations and chromosomal abnormalities
Classe 42
Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals
Classe 45
Granting of licenses to others for the use of industrial property rights and copyright
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/01/2022
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/12/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
07/12/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/10/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
27/07/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
24/07/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/07/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/07/2021
GPNX
NOTIFICATION PROCESSED BY IB
11/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/05/2021
PUBO
PUBLISHED FOR OPPOSITION
11/05/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/04/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
21/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/03/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
31/03/2021
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
13/03/2021
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
13/03/2021
CNCF
ACTION CONTINUING A FINAL - COMPLETED
13/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/02/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
25/09/2020
GNFR
FINAL REFUSAL E-MAILED
25/09/2020
CNFR
FINAL REFUSAL WRITTEN
25/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/06/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/06/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/06/2020
RFNT
REFUSAL PROCESSED BY IB
21/03/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/03/2020
RFRR
REFUSAL PROCESSED BY MPU
05/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/02/2020
CNRT
NON-FINAL ACTION WRITTEN
11/02/2020
MAFR
APPLICATION FILING RECEIPT MAILED
11/02/2020
DOCK
ASSIGNED TO EXAMINER
07/02/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/02/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SMART-FC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.